{
  "schema_version": 1,
  "kind": "drug_profile",
  "generic": "clotrimazole",
  "review_status": "reviewed",
  "origin": "openfda",
  "sections": {
    "adult": [
      {
        "text": "DOSAGE & ADMINISTRATION Gently massage sufficient Clotrimazole Topical Solution, USP 1% into the affected and surrounding skin areas twice a day, in the morning and evening. Clinical improvement, with relief of pruritus, usually occurs within the first week of treatment with Clotrimazole Topical Solution, USP 1%.",
        "source": "US FDA label for clotrimazole (Clotrimazole), section 'dosage and administration', retrieved 2026-08-29",
        "cached_file": "labels/clotrimazole.json",
        "verbatim": true
      }
    ],
    "child": [
      {
        "text": "Safety and effectiveness in pediatric patients have been established for clotrimazole when used as indicated and in the recommended dosage.",
        "source": "US FDA label for clotrimazole (Clotrimazole), section 'pediatric use', retrieved 2026-08-29",
        "cached_file": "labels/clotrimazole.json",
        "verbatim": true
      }
    ],
    "renal": [
      {
        "text": "No kidney-impairment dose in this label. Not a statement that none is needed.",
        "source": "Read and found silent: the US FDA label for clotrimazole (Clotrimazole), retrieved 2026-08-29",
        "cached_file": "labels/clotrimazole.json",
        "verbatim": false
      }
    ],
    "hepatic": [
      {
        "text": "No liver-impairment dose in this label. Not a statement that none is needed.",
        "source": "Read and found silent: the US FDA label for clotrimazole (Clotrimazole), retrieved 2026-08-29",
        "cached_file": "labels/clotrimazole.json",
        "verbatim": false
      }
    ],
    "pregnancy": [
      {
        "text": "Usage in Pregnancy Teratogenic Effects Pregnancy Category B The disposition of 14 C-clotrimazole has been studied in humans and animals.",
        "source": "US FDA label for clotrimazole (Clotrimazole), section 'pregnancy', retrieved 2026-08-29",
        "cached_file": "labels/clotrimazole.json",
        "verbatim": true
      },
      {
        "text": "Clotrimazole is very poorly absorbed following dermal application or intravaginal administration to humans.",
        "source": "US FDA label for clotrimazole (Clotrimazole), section 'pregnancy', retrieved 2026-08-29",
        "cached_file": "labels/clotrimazole.json",
        "verbatim": true
      },
      {
        "text": "(See CLINICAL PHARMACOLOGY ) In clinical trials, use of vaginally applied clotrimazole in pregnant women in their second and third trimesters has not been associated with ill effects.",
        "source": "US FDA label for clotrimazole (Clotrimazole), section 'pregnancy', retrieved 2026-08-29",
        "cached_file": "labels/clotrimazole.json",
        "verbatim": true
      }
    ],
    "lactation": [
      {
        "text": "It is not known whether this drug is excreted in human milk.",
        "source": "US FDA label for clotrimazole (Clotrimazole), section 'nursing mothers', retrieved 2026-08-29",
        "cached_file": "labels/clotrimazole.json",
        "verbatim": true
      },
      {
        "text": "Because many drugs are excreted in human milk, caution should be exercised when clotrimazole is used by a nursing woman.",
        "source": "US FDA label for clotrimazole (Clotrimazole), section 'nursing mothers', retrieved 2026-08-29",
        "cached_file": "labels/clotrimazole.json",
        "verbatim": true
      }
    ]
  }
}